Transmedics Group Inc expected to post a loss of 30 cents a share - Earnings Preview

TransMedics

21/02/2023 03:02

* Transmedics Group Inc  TMDX.OQ   TMDX.O  is expected
to show a
rise in quarterly revenue when it reports  results on February
22. 
    * The Andover Massachusetts-based  company is expected to
report 
a 152.9% increase in revenue to $24.453 million from $9.67
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Transmedics Group
Inc is
for a loss of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Transmedics
Group
Inc is $67​, above​ its last closing price of $66.10. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.43       -0.41      -0.25     Beat    39.3
 Jun. 30 2022  -0.35       -0.35      -0.41     Missed  -17.8
 Mar. 31 2022  -0.39       -0.38      -0.38     Met     0​
 Dec. 31 2021  -0.43       -0.42      -0.46     Missed  -8.5
 ​​Sep.        -0.36       -0.36      -0.47     Missed  -32
 30 2021                                                
 Jun. 30 2021  -0.28       -0.28      -0.39     Missed  -38.3​
 Mar. 31 2021  -0.30       -0.29      -0.29     Met     0.7
 Dec. 31 2020  -0.24       -0.25      -0.23     Beat    7.3
 This summary was machine generated February 21 at 03:02 GMT. 
All figures in US dollars  unless otherwise stated